Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative sleep quality in elderly knee arthroplasty
ChiCTR2500103175Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD), postoperative pain, major depressive disorder (MDD) and 1 more (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Sleep cycles. Started May 2025; status: completed.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)postoperative painmajor depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on ChiCTR2500103175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103175.